Article info

Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

Authors

  1. Correspondence to Dr Xun Xu, Shanghai General Hospital Department of Ophthalmology (aka National Clinical Research Center for Eye Diseases), Shanghai, China; drxuxun{at}sjtu.edu.cn
View Full Text

Citation

Liu K, Wang H, He W, et al
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

Publication history

  • Received January 7, 2021
  • Revised March 31, 2021
  • Accepted April 13, 2021
  • First published May 17, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.